Use the space bar to advance (swipe on mobile).
You can also navigate with the arrows and menu located in the lower corners
Global Medical Affairs Transformation
Covid Impacts on the Life Sciences
SSI Client Profiles
It’s time to lean into the change that’s been thrust upon on us with COVID-19 and use it to deliver long term success for our medical organizations. At SSI we believe that the future impact of medical affairs will not only be shaped by what is implemented but how it is delivered. More »
Leading medical organizations in our view are driven by six core capabilities and six leading competencies- what we call the “SSI 6 x 6.” These have never been more relevant than now. Read Article »
In This Issue Of Wavelengths:
CLINICAL TRIALS
What we are seeing
More distributed sites/PIs
Increased recruitment / patient sizes possible
Virtual / at home monitoring
Unique derived endpoints based on new data capture approaches / techniques
Reduction in number of required costly and invasive scans / tests
What it may mean
Challenges in interpreting new endpoints in the medical community / practice
Sustainability of regulatory acceptance for new approaches
Education of regulators of clinical relevance of data points
Potential for lower cost studies with lower dropout rates
INDUSTRY FOCUS/FUNDING
What we are seeing
Increased focus on diagnostics across therapeutic areas (not just infectious disease)
What it may mean
Increased access to precision diagnostics
Potential for increased diagnoses of various diseases
Challenges to arise in interpreting results and identifying appropriate treatment regimens for complex patients
WORKING ENVIRONMENT
What we are seeing
Moving toward hybrid at home and in-office model
Bifurcates teams and creates more siloes and increased need for communication
Need for collaboration tools not just web communication
What it may mean
Clinical development and collaborative functions will take longer to achieve critical outcomes
Potential for protocol changes and need for re-work
Field engagement will be challenging to maintain and will have to mirror HCP’s interest in continued virtual communication beyond telehealth
EXTERNAL MEETINGS/CONGRESSES
What we are seeing
Hybrid approach for future meetings likely to balance interest in networking/in-person engagement with efficiencies gained in remote CME/learning environment
What it may mean
Publication Poster halls/forums are likely not to survive this adaptation; virtual poster sessions or other forums to get new data into the medical community will be critical
Transforming a Global Medical Information and Education function’s operational capability and performance
Challenge
A global mid-sized pharmaceutical company engaged SSI to help transform their Global Medical Information and Education function’s operational capability and performance. Through 360-degree feedback, including a survey to Global, Regional, Local, and cross-functional stakeholders, best practice insights from subject matter experts, and alignment with client’s strategic goals, our team was able to identify areas of opportunity and develop executable recommendations.
Result
Our recommendations focused on evolving and improving the organization's scalability to quickly and accurately address queries, align on content and planning needs across international stakeholders, and define, gather and analyze metrics. Our scope covered multiple therapeutic areas, geographies, and compounds at various lifecycle stages. To build a holistic set of recommendations, we assessed the various aspects of operational needs, such as people, process, and platforms; and we worked closely with parallel projects focused on bringing in new standard operating procedures and IT systems.
We hope you enjoyed Wavelengths. We'd love to hear your thoughts.
If this link was forwarded to you please be sure to sign-up for future installments.